AbbVie

(NYSE) ABBV

Current Price$202.80

Market Cap$356.49B

Since IPO (2012)+884%

5 Year+110%

1 Year+12%

1 Month-4%

AbbVie Financials at a Glance

Market Cap

$356.49B

Revenue (TTM)

$62.82B

Net Income (TTM)

$3.64B

EPS (TTM)

$2.03

P/E Ratio

99.13

Dividend

$6.74

Beta (Volatility)

0.34 (Low)

Dividend

$6.74

Beta (Volatility)

0.34 (Low)

Price

$202.80

Volume

145,647

Open

$202.51

Price

$202.80

Volume

145,647

Open

$202.51

Previous Close

$202.80

Daily Range

$201.85 - $205.38

52-Week Range

$176.57 - $244.81

Dividend

$6.74

Beta (Volatility)

0.34 (Low)

Price

$202.80

Volume

145,647

Open

$202.51

Previous Close

$202.80

Daily Range

$201.85 - $205.38

52-Week Range

$176.57 - $244.81

ABBV News

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

Prosper Junior BakinyMay 11, 2026

Best Pharmaceutical Stocks for 2026 and How to Invest

Keith SpeightsMay 8, 2026

The Largest Healthcare Companies by Market Cap in May 2026

Lyle DalyMay 8, 2026

Page 1

ABBV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AbbVie

Industry

Biotechnology

Sector

Health Care

Employees

57,000

CEO

Robert A. Michael, MBA, CPA

Website

www.abbvie.com

Headquarters

North Chicago, IL 60064-6400, US

ABBV Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

28%

Net Income Margin

Return on Equity

15222%

Return on Capital

18%

Return on Assets

Earnings Yield

1.01%

Dividend Yield

3.34%

Payout Ratio

3.25%

Stock Overview

Market Cap

$356.49B

Shares Outstanding

1.77B

Volume

145.65K

Avg. Volume

6.93M

Financials (TTM)

Gross Profit

$42.96B

Operating Income

$20.09B

EBITDA

$17.63B

Operating Cash Flow

$19.03B

Capital Expenditure

$1.21B

Free Cash Flow

$17.82B

Cash & ST Invst.

$5.26B

Total Debt

$69.07B

AbbVie Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$15.00B

+12.4%

Gross Profit

$12.53B

+34.2%

Gross Margin

83.54%

N/A

Market Cap

$356.49B

N/A

Market Cap/Employee

$6.48M

N/A

Employees

55,000

N/A

Net Income

$699.00M

-45.6%

EBITDA

$4.73B

+7.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$63.47B

+1.9%

Accounts Receivable

$12.48B

+0.0%

Inventory

$5.05B

+11.6%

Long Term Debt

$64.53B

+0.0%

Short Term Debt

$8.33B

+55.3%

Return on Assets

2.67%

N/A

Return on Invested Capital

18.38%

N/A

Free Cash Flow

$3.56B

+154.6%

Operating Cash Flow

$3.83B

+134.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

UNHUnitedHealth Group Incorporated

UNHUnitedHealth Group Incorporated$384.44+1.17%

AZNAstraZeneca PLC

AZNAstraZeneca PLC$181.86-0.54%

NVSNovartis AG

NVSNovartis AG$145.23-0.55%

MRKMerck & Co., Inc.

MRKMerck & Co., Inc.$111.30-0.07%

NVONovo Nordisk A/S

NVONovo Nordisk A/S$46.40+0.72%

JNJJohnson & Johnson

JNJJohnson & Johnson$221.43+0.05%

AMGNAmgen Inc.

AMGNAmgen Inc.$329.59-0.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.84+0.08%

NOKNokia

NOKNokia$13.92+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.96+0.01%

CRCLCircle Internet Group

CRCLCircle Internet Group$131.76+0.16%

MARAMara Holdings

MARAMara Holdings$13.39+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.22-0.01%

FFord Motor Company

FFord Motor Company$12.05-0.02%

Questions About ABBV

What is the current price of AbbVie?

AbbVie is trading at $202.80 per share.

What is the 52-week range for AbbVie?

Over the past 52 weeks, AbbVie has traded between $176.57 and $244.81.

How much debt does AbbVie have?

As of the most recent reporting period, AbbVie reported total debt of $72.86B.

How much cash does AbbVie have on hand?

AbbVie reported $9.39B in cash and cash equivalents in its most recent financial results.

What is AbbVie’s dividend yield?

AbbVie currently has a dividend yield of 3.34%.

AbbVie

AbbVie Financials at a Glance

ABBV News

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

Best Pharmaceutical Stocks for 2026 and How to Invest

The Largest Healthcare Companies by Market Cap in May 2026

Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?

Want to Collect a High Dividend Every Month? Invest in These 3 Stocks

AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook

3 of the Best Dividend Stocks to Buy in May 2026

20 Best High-Yield Dividend Stocks to Buy in 2026

ABBV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About AbbVie

ABBV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

AbbVie Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ABBV

What is the current price of AbbVie?

What is the 52-week range for AbbVie?

How much debt does AbbVie have?

How much cash does AbbVie have on hand?

What is AbbVie’s dividend yield?

Premium Investing Services